Trends in co-prescribing of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in Ireland

AIMS: (i) To examine the trends in co-prescribing of angiotensin converting enzyme inhibitor (ACEI) and angiotensin-II receptor blocker (ARB) therapy and (ii) to examine the influence of major clinical trials (CALM, COOPERATE, VALIANT and ONTARGET) on co-prescribing. METHODS: The Irish HSE-Primary C...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Wan Md Adnan, Wan A H, Zaharan, Nur L, Bennett, Kathleen, Wall, Catherine A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Science Inc 2011
Aiheet:
Pharmacoepidemiology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3045556/
https://ncbi.nlm.nih.gov/pubmed/21284706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03835.x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia